Abstract Two new stilbenolignans and one novel lactone stilbenolignan with a seven-membered ring were biomimetically synthesized by an oxidative coupling reaction and acid-catalyzed polymerization with either isorhapontigenin and ferulic acid or sinapinic acid, respectively, as the starting materials. The structures of the stilbenolignans were defined using spectral analysis and their mechanisms of formation are discussed. Anti-oxidant and anti-inflammatory activities of the novel stilbenolignans were tested, and the lactone stilbenolignan was observed to exhibit potent anti-oxidant activity.
Introduction
Stilbenolignans are a type of natural compound formed from stilbene and phenylpropanoid. So far only a few stilbenolignans have been found as natural products, indicating their narrow distribution and limited production in plants [1] [2] [3] [4] [5] [6] . There is little information in the literature with regard to the biological activities and biomimetic synthesis of stilbenolignans [7] [8] [9] . In previous studies from our research group, five natural stilbenolignans, gnetucleistol F, gnetofuran A, lehmbachol D, gnetifolin F, and gnetumontanin C were isolated from Gnetum cleistostachyum. Four of these compounds were synthesized by an oxidative coupling reaction, and they were found to exhibit potent anti-inflammatory activities in pharmacological testing 9 . With our continued investigation into the biomimetic synthesis of stilbenolignans, two new stilbenolignan derivatives 1 and 2 were synthesized through an oxidative coupling reaction with ferulic acid (3), sinapinic acid (4) and isorhapontigenin (5) as the starting materials. Further, a novel lactone stilbenolignan derivative 6 and a known tetralin derivative 9 were synthesized by acid-catalyzed polymerization of ferulic acid and isorhapontigenin ( Fig. 1 ) 10 . Tests for antioxidative and anti-inflammatory activities showed that compound 6 could exhibit potent anti-oxidant activity with an IC 50 value of 5.27 Â 10 À6 M. Here, we report the synthesis, structural elucidation, possible mechanisms of formation and activities of these novel stilbenolignans.
Results and discussion
An esterification reaction of ferulic acid in methanol saturated with hydrochloric acid was carried out at room temperature to obtain methyl ferulate (7) in 96% yield. Then, an oxidative coupling reaction of methyl ferulate and isorhapontigenin in acetone, with Ag 2 O as oxidant, was carried out to generate stilbenolignan 1. Similarly, sinapinic acid was converted into its methyl ester 8 in methanol saturated with hydrochloric acid, which then resulted in the production of stilbenolignan 2 through an oxidative coupling reaction with isorhapontigenin in acetone, with Ag 2 O as the oxidant. A solution of ferulic acid and isorhapontigenin in concentrated hydrochloric acid was stirred for 72 h at room temperature to obtain stilbenolignan 6 and tetralin derivative 9 10 . Of the two, stilbenoligan 6 was found to be a novel derivative of gnetumontanin C. The structures of products 1, 2 and 6 were established as described below.
Compound 1 was a light grayish amorphous powder. On FAB-MS analysis, the compound showed a molecular ion peak at m/z 464 [M] þ , and together with the 1 H NMR and 13 C NMR spectra (Table 1) , indicated a molecular formula of C 26 H 24 O 8 , indicating that stilbenolignan 1 could be a dimer of an isorhapontigenin and a methyl ferulate. The ultraviolet spectrum of 1 showed absorption bands at l max 205 and 325 nm, indicating the presence of a strong conjugated system in 1; on IR spectroscopy, the compound exhibited evidence of hydroxyls (n max 3400 cm À1 ), an ester carbonyl group Figure 1 Synthetic routes for compounds 1, 2, 6, and 9. carbons. These data indicated that 1 had a similar skeletal structure to that of gnetofuran A, isolated from Gnetum cleistostachyum 9 . The difference between the two was that a hydroxymethyl group at C-8a in gnetofuran A was substituted by a methoxycarbonyl in compound 1. In the NOE difference experiments (Fig. 2) , the enhancements of H-2b, H-6b, and H6a on irradiation of H-8b, and the enhancements of H-2b and H-6b on irradiation of H-7b confirmed the trans-relative configuration of H-7b and H-8b. Accordingly, the structure of 1 was constructed, and it appeared to be a new derivative of the natural stilbenolignan gnetofuran A. . Refined analysis of the NMR spectral data of the two compounds revealed that the major difference between them was the replacement of a hydroxymethyl group in gnetucleistol F by a methoxycarbonyl in 2. In the NOE difference experiments (Fig. 2) , irradiation of H-7b resulted in enhancement of H-2b (6b), and irradiation of H-8b resulted in enhancement of H-2b (6b) and H-6a, indicating the transrelative configuration of H-7b and H-8b. Therefore, the structure of 2 was determined.
Compound 6 (Table 2) , provided a molecular formula of C 25 H 22 O 7 , indicating that 6 could be a dimer of an isorhapontigenin and a ferulic acid. The UV spectrum showed absorption bands at l max 207 and 283 nm, indicating the presence of a strong conjugated system in 6. The IR spectrum showed the existence of hydroxyl group (n max 3344 cm À1 ), ester carbonyl (n max 1749 cm À1 ), double bond (n max 1631 cm À1 ), and an aromatic ring (n max 1591, 1514 and 1466 cm À1 3 .80 (3H, s) were observed. The 13 C NMR spectrum of 6 showed 25 carbon signals (a carbonyl carbon, 18 aromatic carbons, 4 aliphatic carbons, and 2 methoxyl carbons). These data indicated that 6 possessed a structure similar to gnetumontanin C, which is a stilbene derivative containing a lactonic ring 6 . Compound 6 has two aliphatic carbon signals and three aliphatic proton signals more than gnetumontanin C, and has two less olefinic carbon signals than the stilbene derivative; therefore, the structure of 6 was noted to have one ring more than in gnetumontanin C. This was confirmed by a refined analysis of the HMBC spectrum (Fig. 3) . In the HMBC spectrum, the correlations between H-7a and C-1a, C-2a, C-6a, C-8a, C-1b, and C-6b; H-8aa and C-7a, C-9a, C-10a, C14a, and C-6b; H-8ab and C-1a, C-7a, C-9a, C-10a, and C14a, and H-5b and C-1b, C-4b, and C-7a indicated that the connection between C-7a and C-6b resulted in the formation of a seven-membered ring in the structure of 6, which was further confirmed by the crosses of H-7b and C-1b, C-2b, C6b, C-8b, C-9b, C-9a, C-10a, and C-11a. In addition, the relative configuration of 6 was discussed. In NOE experiments (Fig. 3) , the enhancements of H-8aa and H-8ba on irradiation of H-7b implied the cis configuration of H-7b, H-8aa, and H8ba. The enhancements of H-8ba and H-2b on irradiation of H-8bb indicated a trans configuration of H-8bb and H-7b. The enhancements of H-8ab, H-2a, and H-5b on irradiation of H7a, and the enhancements of H-8ab and H-7b on irradiation of H-8aa indicated a cis configuration of H-7a and H-8ab. Therefore, the structure of 6 was elucidated as shown in Fig. 1 , and was considered a new derivative of the naturally occurring gnetumontanin C.
On the basis of the oxidative coupling reaction of isorhapontigenin [7] [8] [9] , the possible mechanisms of formation of stilbenolignans 1 and 2 were interpreted as described below: with Ag 2 O as the oxidant, isorhapontigenin produced the free radicals R 4 Á , R 5 Á , and R 8 Á , and methyl ferulate (or methyl sinapate) produced Re 8 Á ) generates unstable intermediates 10a (or 10b), which produced 1 (as well as 2, Fig. 5 ) through intramolecular cyclization. In addition, the possible mechanisms of acid-catalyzed polymerization of compounds 3 and 5 may be hypothesized as follows: the esterification of 3 and 5 produced an intermadiate 11.
An acidic protonation of the olefinic bond on the ferulic acid moiety was followed by cyclization to produce intermediate 12, which formed 6 after undergoing a second cyclization (Fig. 6 ). In the course of the reaction, two cyclization reactions may be carried out in coordination because no product lacking a seven-membered ring was observed.
The pharmacological activities of anti-oxidation and antiinflammation have been evaluated. As shown in Table 3 , none was found to be active on TNFa (dexamethasone was used as a positive control for TNFa with IC 50 value of 1 Â 10 À6 M).
As the inhibitory rate of malondialdehyde (MDA) formation for compound 9 at a concentration of 1 Â 10 À5 M was À24.48%, and the IC 50 value of MDA for 6 was 5.27 Â 10 À6 M (Vitamine E was used as a positive control for MDA with IC 50 value of 1 Â 10 À6 M), indicating that the 6 could exhibit potent anti-oxidant activity.
Experimental

General experimental procedures
Melting points of compounds were determined with a GERMANY-68992 apparatus. Optical rotations were determined on a Perkin-Elmer digital polarimeter. The IR spectra were run on a Perkin-Elmer 683 infrared spectrometer in KBr pellets. The UV spectrum was obtained on a Shimadzu UV-300 spectrophotometer. NMR spectra were carried out on AM 500 using TMS as internal standard. High-performance Figure 6 Possible formation routes of 6 in HCl. liquid chromatography was carried out on a Waters 411 equipped with a 2487 detector and a 510 pump. The EI-MS and HR-FAB-MS were obtained on a QB-200 mass spectrometer.
Synthesis of compounds 7 and 8
Compound 3 (8 g, 41.24 mmol) was dissolved in methanol saturated with hydrochloric acid. The solution was kept standing for 48 h at room temperature, with occasional stirring. The solution was concentrated to obtain 7 (8.2 g), with a yield of 96%. Similarly, compound 4 was treated using the same method to afford 8 (1.0 g), with a yield of 96%.
3.3. Synthesis of stilbenolignans 1 and 2
1.5 g Ag 2 O was added to the solution of methyl ferulate 7 (15 mg) and isorhapontigenin 5 (20 mg) in 10 mL acetone. The solution was stirred for 8 h at room temperature. The mixture was filtered and the filtrate was concentrated in vacuo. The residue obtained was subjected to silica gel column chromatography to generate stilbenolignan 1 (5 mg). In addition, methyl sinapate 8 (15 mg) and isorhapontigenin 5 (20 mg) were treated using the same method to obtain stilbenolignan 2 (6 mg).
Synthesis of stilbenolignan 6 and tetralin derivative 9
A solution of 1 g ferulic acid 3 and 1 g isorhapontigenin 5 in 40 mL concentrated hydrochloric acid was stirred for 72 h at room temperature. The mixture was concentrated in vacuo and 50 mL of water was added. The suspension was extracted with EtOAc (3 Â 50 mL); the combined organic layer was concentrated and subjected to silica gel column chromatography with CHCl 3 -MeOH (20:1-5:1, v/v) as the eluent to afford fractions 1 and 2. Fraction 1 was further purified on silica gel column chromatography with petrol ether-acetone (2:1, v/v) to get stilbenolignan 6 (50 mg). Fraction 2 was dissolved in methanol saturated with hydrochloric acid and the solution was kept standing for 2 days at room temperature, after which the mixture was concentrated and subjected to silica gel column chromatography with a cyclohexane-acetone (2:1, v/v) eluent to obtain the tetralin derivative 9 (500 mg). 
Anti-inflammatory bioassay
Effects of the compounds on TNFa activity were analyzed in the supernatant of cultured mouse peritoneal macrophages stimulated with lipopolysaccharide (LPS). Mouse peritoneal macrophage (2 Â 10 9 cells/mL) protein incubated with various concentrations of compounds was stimulated by LPS (10 mg/ mL) for 12 h. TNFa bioactivity in the supernatant was quantified by measuring the absorbance at 570 nm after staining L929 with crystalviolet 11 .
Anti-oxidant bioassay.
The anti-oxidative ability of these compounds was determined by the content of MDA, a compound that was produced during microsomal lipid peroxidation induced by ferrouscysteine. MDA was detected by using the thiobarbituricacid (TBA) method. Briefly, 1 mg/mL microsomal protein, different concentrations of compound or vehicle, and 0.2 mM cysteine in 0.1 M PBS were incubated for 15 min at 37 1C, after which 0.5 mM ferrous sulfate was added and incubated for 15 min at 37 1C again. An equal volume of 20% TCA was added to terminate the reaction and centrifuged for 10 min at 3000 rpm. The supernatant fractions were mixed with 0.67% TBA for 10 min at 100 1C. After cooling, the MDA was quantified by determining the absorbance at 532 nm and then the inhibition rate was calculated 12 .
